Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Parkinson's Disease

Free Subscription 27.08.2018 1 BMC Neurol 1 J Neural Transm (Vienna) 1 J Neurochem 2 Mov Disord 1 Nervenarzt 1 Neurochem Res 2 Neurol Clin Pract 1 Neurosci Lett 1 PLoS Med 1 PLoS One 1 Proc Natl Acad Sci U S A 1 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

BMC Neurol

1. WANG G, Cui HL, Liu J, Xiao Q, et al
   Current approaches for the management of Parkinson's disease in Chinese hospitals: a cross-sectional survey.
   BMC Neurol. 2018;18:122.
   PubMed     Text format     Abstract available
   
   

   
   J Neural Transm (Vienna)

2. ENGELS G, McCoy B, Vlaar A, Theeuwes J, et al
   Clinical pain and functional network topology in Parkinson's disease: a resting-state fMRI study.
   J Neural Transm (Vienna). 2018 Aug 21. pii: 10.1007/s00702-018-1916.
   PubMed     Text format     Abstract available
   
   

   
   J Neurochem

3. GALLEA JI, Ambroggio EE, Vilcaes AA, James NG, et al
   Amyloid oligomerization of the Parkinson's disease related protein alpha-synuclein impacts on its curvature-membrane sensitivity.
   J Neurochem. 2018 Aug 24. doi: 10.1111/jnc.14573.
   PubMed     Text format     Abstract available
   
   

   
   Mov Disord

4. WITEK N, Stebbins GT, Goetz CG
   What influences placebo and nocebo responses in Parkinson's disease?
   Mov Disord. 2018 Aug 22. doi: 10.1002/mds.27416.
   PubMed     Text format     Abstract available
   
   
5. LERCHE S, Liepelt-Scarfone I, Wurster I, Schulte C, et al
   Polygenic load: Earlier disease onset but similar longitudinal progression in Parkinson's disease.
   Mov Disord. 2018 Aug 22. doi: 10.1002/mds.27427.
   PubMed     Text format     Abstract available
   
   

   
   Nervenarzt

6. HIRJAK D, Kubera KM, Bienentreu S, Thomann PA, et al
   [Antipsychotic-induced motor symptoms in schizophrenic psychoses-Part 1 : Dystonia, akathisia und parkinsonism].
   Nervenarzt. 2018 Aug 20. pii: 10.1007/s00115-018-0582.
   PubMed     Text format     Abstract available
   
   

   
   Neurochem Res

7. REKHA KR, Inmozhi Sivakamasundari R
   Geraniol Protects Against the Protein and Oxidative Stress Induced by Rotenone in an In Vitro Model of Parkinson's Disease.
   Neurochem Res. 2018 Aug 23. pii: 10.1007/s11064-018-2617.
   PubMed     Text format     Abstract available
   
   

   
   Neurol Clin Pract

8. 
   Erratum: A practical approach to detection and treatment of depression in Parkinson disease and dementia.
   Neurol Clin Pract. 2018;8:278.
   PubMed     Text format     Abstract available
   
   
9. 
   Erratum: What predicts falls in Parkinson disease? Observations from the Parkinson's Foundation Registry.
   Neurol Clin Pract. 2018;8:278.
   PubMed     Text format     Abstract available
   
   

   
   Neurosci Lett

10. CHEN Y, Cao B, Chen X, Ou R, et al
    The relationship between four GWAS-identified loci in Alzheimer's disease and the risk of Parkinson's disease, amyotrophic lateral sclerosis, and multiple system atrophy.
    Neurosci Lett. 2018 Aug 22. pii: S0304-3940(18)30569.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Med

11. NAM GE, Kim SM, Han K, Kim NH, et al
    Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study.
    PLoS Med. 2018;15:e1002640.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

12. CHOUDHURY GR, Daadi MM
    Charting the onset of Parkinson-like motor and non-motor symptoms in nonhuman primate model of Parkinson's disease.
    PLoS One. 2018;13:e0202770.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

13. TELKES I, Viswanathan A, Jimenez-Shahed J, Abosch A, et al
    Local field potentials of subthalamic nucleus contain electrophysiological footprints of motor subtypes of Parkinson's disease.
    Proc Natl Acad Sci U S A. 2018 Aug 21. pii: 1810589115.
    PubMed     Text format     Abstract available
    
    

    
    Rev Neurol (Paris)

14. ALEXOUDI A, Alexoudi I, Gatzonis S
    Parkinson's disease pathogenesis, evolution and alternative pathways: A review.
    Rev Neurol (Paris). 2018 Aug 18. pii: S0035-3787(17)30683.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: